L. Tye
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- Lung Cancer Treatments and Mutations 16
- Advanced Breast Cancer Therapies 2
- Genetics 8
- Estrogen and related hormone effects 8
- Co-authors
- Richard C. Chao (12 shared papers)Xin Huang (3 shared papers)Neal J. Meropol (2 shared papers)Matthew H. Kulke (2 shared papers)Paulina Selaru (4 shared papers)David P. Ryan (2 shared papers)Jim Z. Li (1 shared paper)Charles M. Baum (1 shared paper)
- Journals
- Annals of Oncology (5 papers)Journal of Clinical Oncology (4 papers)British Journal of Cancer (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Life Sciences (2 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
L. Tye
28 papers receiving 3k citations
L. Tye's Hit Papers
Peers
Comparison fields: 5 of 75
- Pulmonary and Respiratory Medicine 1.8k
- Cancer Research 238
- Epidemiology 472
- Oncology 282
- Pharmacology 62
Countries citing papers authored by L. Tye
This map shows the geographic impact of L. Tye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Tye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Tye more than expected).
Fields of papers citing papers by L. Tye
This network shows the impact of papers produced by L. Tye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Tye. The network helps show where L. Tye may publish in the future.
Co-authors
The 25 scholars most cited alongside L. Tye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer Hit paper breakdown → | 2014 | 1638 |
| 2 | Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors Hit paper breakdown → | 2008 | 509 |
| 3 | 2008 | 285 | |
| 4 | 2012 | 179 | |
| 5 | 2009 | 113 | |
| 6 | 2013 | 47 | |
| 7 | 2010 | 46 | |
| 8 | 2015 | 41 | |
| 9 | 2009 | 35 | |
| 10 | Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen. | 1995 | 33 |
| 11 | 2012 | 22 | |
| 12 | Anastrozole: a new selective nonsteroidal aromatase inhibitor. | 1997 | 20 |
| 13 | 2000 | 19 | |
| 14 | 2013 | 18 | |
| 15 | 2012 | 15 | |
| 16 | 1980 | 14 | |
| 17 | 1999 | 13 | |
| 18 | 2011 | 10 | |
| 19 | RANDOMIZED PHASE II STUDY OF SUNITINIB (SU) PLUS ERLOTINIB (E) VS. PLACEBO (P) PLUS E FOR THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) | 2010 | 8 |
| 20 | 2014 | 8 |
About L. Tye
L. Tye is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Pediatrics, Perinatology and Child Health, Oncology and Endocrinology, Diabetes and Metabolism, having authored 30 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Estrogen and related hormone effects (8 papers), Birth, Development, and Health (4 papers), Adrenal Hormones and Disorders (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer therapeutics and mechanisms (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.8k citations), Cancer Research (238 citations), Epidemiology (472 citations), Oncology (282 citations) and Pharmacology (62 citations). L. Tye has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Richard C. Chao, Xin Huang, Neal J. Meropol, Matthew H. Kulke, Paulina Selaru, David P. Ryan, Jim Z. Li, Charles M. Baum, Heinz‐Josef Lenz and James A. Posey. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, British Journal of Cancer, Cancer Chemotherapy and Pharmacology and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.